APA (7th ed.) Citation

Foley, P., Manuelpillai, N., Dolianitis, C., Cains, G. D., Mate, E., Tronnberg, R., & Baker, C. (2022). Secukinumab treatment demonstrated high drug survival and sustained effectiveness in patients with severe chronic plaque psoriasis: 21‐month analysis in Australian routine clinical practice (SUSTAIN study). Australasian Journal of Dermatology, 63(3), 303. https://doi.org/10.1111/ajd.13895

Chicago Style (17th ed.) Citation

Foley, Peter, Nick Manuelpillai, Con Dolianitis, Geoffrey D. Cains, Eric Mate, Rebecca Tronnberg, and Christopher Baker. "Secukinumab Treatment Demonstrated High Drug Survival and Sustained Effectiveness in Patients with Severe Chronic Plaque Psoriasis: 21‐month Analysis in Australian Routine Clinical Practice (SUSTAIN Study)." Australasian Journal of Dermatology 63, no. 3 (2022): 303. https://doi.org/10.1111/ajd.13895.

MLA (9th ed.) Citation

Foley, Peter, et al. "Secukinumab Treatment Demonstrated High Drug Survival and Sustained Effectiveness in Patients with Severe Chronic Plaque Psoriasis: 21‐month Analysis in Australian Routine Clinical Practice (SUSTAIN Study)." Australasian Journal of Dermatology, vol. 63, no. 3, 2022, p. 303, https://doi.org/10.1111/ajd.13895.